Italy is Europe’s third largest pharmaceutical market, yet it ranks only ninth in the number of NIH-registered clinical trials per capita. The aim of our study was to explore stakeholders’ perception of Italy as place to undertake clinical trials, and to estimate the potential economic impact of selected reforms in terms of incremental trial activity.
Towards a more competitive Italy in clinical research: the survey of attitudes towards trial sites in Europe (the SAT-EU study™)
JOMMI, CLAUDIO;TARRICONE, ROSANNA;
2015
Abstract
Italy is Europe’s third largest pharmaceutical market, yet it ranks only ninth in the number of NIH-registered clinical trials per capita. The aim of our study was to explore stakeholders’ perception of Italy as place to undertake clinical trials, and to estimate the potential economic impact of selected reforms in terms of incremental trial activity.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
EpidBioPubHealth2015.pdf
non disponibili
Descrizione: EpidemiologyBioPublicHealth2015
Tipologia:
Pdf editoriale (Publisher's layout)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
1.21 MB
Formato
Adobe PDF
|
1.21 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.